Lee's Pharmaceutical Holdings Ltd (0950.HK)
7.03HKD
18 Apr 2019
HK$-0.15 (-2.09%)
HK$7.18
HK$7.13
HK$7.14
HK$6.93
428,000
497,650
HK$12.90
HK$5.29
Latest Key Developments (Source: Significant Developments)
Lee's Pharmaceutical Holdings Issues Profit Warning
March 4 (Reuters) - Lee's Pharmaceutical Holdings Ltd <0950.HK>::NET PROFIT ATTRIBUTABLE FOR YEAR ANTICIPATED WILL INCREASE BY ABOUT 50%.EXPECTED RESULT DUE TO NON-RECURRING GAIN FROM DEEMED DISPOSAL OF INTERESTS IN CVIE THERAPEUTICS LTD IN DEC 2018. Full Article
Lee's Pharmaceutical Holdings Posts Qtrly Profit Attributable Of HK$71.7 Mln
Nov 29 (Reuters) - Lee's Pharmaceutical Holdings Ltd <0950.HK>::QTRLY REVENUE HK$299.2 MILLION VERSUS HK$275 MILLION.QTRLY PROFIT ATTRIBUTABLE HK$71.7 MILLION VERSUS HK$61.8 MILLION.APPROVALS FOR TRAZODONE AND PRULIFLOXACIN ARE EXPECTED TO BE RECEIVED IN Q1 OF 2019..LEE'S PHARMA HOLDINGS - CLINICAL STUDY ON NATULAN, BIOEQUIVALENCE STUDY FOR AZILSARTAN COMPLETED; IDL SUBMISSIONS EXPECTED BY END OF 2018..RESEARCH AND DEVELOPMENT EXPENDITURE OF GROUP IS EXPECTED TO INCREASE SUBSTANTIALLY IN COMING YEARS.LEE'S PHARMACEUTICAL HOLDINGS - GROUP DECIDED TO GRADUALLY SEPARATE RESEARCH AND DEVELOPMENT ACTIVITIES IN ONCOLOGY AND OPHTHALMOLOGY FROM ITS CORE REVENUE STREAM. Full Article
Lee's Pharmaceutical Says Unit & Perfect Concept Holdings Subscribed Shares Of China Oncology Focus
Oct 22 (Reuters) - Lee's Pharmaceutical Holdings Ltd <0950.HK>::UNIT & PERFECT CONCEPT HOLDINGS SUBSCRIBED FOR 65,000 & 35,000 SHARES OF CHINA ONCOLOGY FOCUS AT $14 MILLION & $7.5 MILLION RESPECTIVELY. Full Article
Lee's Pharmaceutical Holdings Says Zhaoke Pharmaceutical Co To Sell Assets For HK$7.3 Mln
July 20 (Reuters) - Lee's Pharmaceutical Holdings Ltd <0950.HK>::LPHK AGREES TO SELL LPHK ASSETS FOR HK$106.5 MILLION TO CHINA ONCOLOGY FOCUS LIMITED.ZHAOKE PHARMACEUTICAL CO TO SELL ASSETS TO CHINA ONCOLOGY FOCUS FOR HK$7.3 MILLION. Full Article
Lee's Pharmaceutical Says Lee's International Shall Advance Additional Loan Of HK$5 MLN In PPI
July 20 (Reuters) - Lee's Pharmaceutical Holdings Ltd <0950.HK>::ENTERED INTO SUPPLEMENTAL AGREEMENT; LEE'S INTERNATIONAL SHALL ADVANCE TO PPI AN ADDITIONAL LOAN IN AMOUNT OF HK$5 MILLION. Full Article
Lee's Pharmaceutical Says Gets Approval For Conducting Clinical Trials For TG02 From China FDA
June 14 (Reuters) - Lee's Pharmaceutical Holdings Ltd <0950.HK>::CHINA FOOD AND DRUG ADMINISTRATION GRANTED APPROVAL FOR CONDUCTING CLINICAL TRIALS FOR TG02. Full Article
Lee's Pharmaceutical Posts Q1 Profit Attributable Of HK$70.2 Mln
May 24 (Reuters) - Lee's Pharmaceutical Holdings Ltd <0950.HK>::Q1 PROFIT ATTRIBUTABLE HK$70.2 MILLION VERSUS HK$46.4 MILLION.QTRLY REVENUE HK$281.905 MILLION VERSUS HK$226.200 MILLION. Full Article
Lee's Pharmaceutical Holdings says qtrly profit attributable HK$61.8 mln
Nov 23 (Reuters) - Lee's Pharmaceutical Holdings Ltd <0950.HK>:Qtrly profit attributable to owners of company HK$61.8 million versus HK$72.8 million.Qtrly revenue HK$275.0 million versus HK$248.9 million a year ago. Full Article
Earnings vs. 
Estimates